These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 161105)

  • 1. [Combined inhalation of salbutamol and ipratropin in chronic bronchial obstruction].
    Kok-Jensen A
    Ugeskr Laeger; 1979 Jul; 141(30):2039-41. PubMed ID: 161105
    [No Abstract]   [Full Text] [Related]  

  • 2. Nebulised ipratropium bromide and salbutamol in chronic bronchitis.
    Lees AW; Allan GW; Smith J
    Br J Clin Pract; 1980; 34(11-12):340-2. PubMed ID: 6450601
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ultrasonic spray protection against bronchospasm. Comparison of fenoterol and a combination of salbutamol and ipratropium bromide].
    Gribaldo E; Ardizzi A; Oliaro A; Galietti F; Giorgis GE; Miravalle C
    Minerva Med; 1987 Oct; 78(20):1539-41. PubMed ID: 2959883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of an adrenergic-parasympatholytic aerosol combination on the respiratory function].
    Rossi A; Rampulla C; Nascimbene T; Casali L
    Minerva Med; 1979 Jan; 70(4):333-46. PubMed ID: 155228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of salbutamol and ipratropium in chronic bronchitis and chronic airflow limitation.
    Barnes D; Delaney JC
    Br J Clin Pract; 1988 Sep; 42(9):372-6. PubMed ID: 2978246
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of ipratropium bromide and salbutamol in a long-term trial in asthmatic and bronchitic patients in a cold climate.
    Laitinen LA; Poppius H; Haahtela T
    Scand J Respir Dis Suppl; 1979; 103():163-9. PubMed ID: 155293
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison by double-blind study of the combination of an aerosol of salbutamol and ipratropium bromide and its individual effect in chronic bronchitis and bronchial asthma].
    Baños Hidalgo P; Ramos Martos A; Cabrera Moreno R; Luque Leal J; Palacios Giner A
    Rev Clin Esp; 1983 Nov; 171(4):265-8. PubMed ID: 6229844
    [No Abstract]   [Full Text] [Related]  

  • 8. A double blind cross-over study of maximal expiratory flows and arterial blood gas tensions in normals, asthmatics and bronchitics after salbutamol and ipratropin.
    Thiessen B; Pedersen OF
    Scand J Respir Dis Suppl; 1979; 103():170-7. PubMed ID: 155294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of freon inhalation on maximal expiratoryflows and heart rhythm after treatment with salbutamol and ipratropium bromide.
    Thiessen B; Pedersen OF
    Eur J Respir Dis; 1980 Jun; 61(3):156-61. PubMed ID: 6449369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of a combination of bronchodilators.
    Casali L; Grassi C; Rampulla C; Rossi A
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):277-80. PubMed ID: 157338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value and limitations of salbutamol in the treatment of the obstructive syndrome. Comparative study with a synthetic atropine-like agent].
    Uffholtz H; Sadoul P; Lempereur L; Sentissi M
    Minerva Med; 1976 Mar; 67(15):917-21. PubMed ID: 131259
    [No Abstract]   [Full Text] [Related]  

  • 12. Salbutamol and ipratropium bromide solution in the treatment of bronchospasm in asthmatic children.
    Boner AL; De Stefano G; Niero E; Vallone G; Gaburro D
    Ann Allergy; 1987 Jan; 58(1):54-8. PubMed ID: 2948430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ipratropium bromide, salbutamol and prednisolone in bronchial asthma and chronic bronchitis.
    Lightbody IM; Ingram CG; Legge JS; Johnston RN
    Br J Dis Chest; 1978 Jul; 72(3):181-6. PubMed ID: 151547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of anticholinergic drugs in the treatment of bronchospastic conditions].
    Wesołowski S
    Pneumonol Pol; 1985 Jan; 53(1):49-52. PubMed ID: 3160010
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative trial of Atrovent and Ventolin in chronic bronchitis.
    Jaffé GV; Grimshaw JJ; Cox GA
    Practitioner; 1980 Apr; 224(1342):433-6. PubMed ID: 6448997
    [No Abstract]   [Full Text] [Related]  

  • 16. Maximal expiratory flows and forced vital capacity in normal, asthmatic and bronchitic subjects after salbutamol and ipratropium bromide.
    Thiessen B; Pedersen OF
    Respiration; 1982; 43(4):304-16. PubMed ID: 6213991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of the inhalation of an atropine derivative (ipratropium bromide) in powder form on respiratory mechanics in obstructive airway diseases].
    Götz R; Siemon G
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():927-8. PubMed ID: 6227883
    [No Abstract]   [Full Text] [Related]  

  • 18. [Controlled clinical study of the effects of a single aerosol administration of a fenoterol-ipratropium bromide combination in comparison with salbutamol].
    Ginesu F; Ortu AR; Schena GP; Deiola G; Polo F
    Arch Monaldi; 1983; 38(5-6):241-54. PubMed ID: 6238579
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of aerosol ipratropium bromide and salbutamol on exercise tolerance in chronic bronchitis.
    Leitch AG; Hopkin JM; Ellis DA; Merchant S; McHardy GJ
    Thorax; 1978 Dec; 33(6):711-3. PubMed ID: 154748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma.
    Petrie GR; Palmer KN
    Br Med J; 1975 Feb; 1(5955):430-2. PubMed ID: 1090337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.